Vanda Pharmaceuticals Inc. (VNDA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 51.72M | 57.22M | 56.26M | 52.59M | 50.04M | 53.19M | 47.65M | 50.47M | 47.46M | 45.27M | 38.81M | 46.06M |
| Revenue Growth % | 3.35% | 7.58% | 18.06% | 4.19% | 5.43% | 17.48% | 22.76% | 9.59% | -24.06% | -29.79% | -40.58% | -28.47% |
| Cost of Goods Sold | 0 | 3.83M | 2.95M | 4.49M | 3.52M | 2.59M | 2.55M | 4.49M | 5.46M | 3.46M | 3.06M | 3.5M |
| COGS % of Revenue | - | 6.7% | 5.25% | 8.53% | 7.04% | 4.87% | 5.35% | 8.89% | 11.5% | 7.64% | 7.89% | 7.6% |
| Gross Profit | 0 | 53.38M | 53.3M | 48.1M | 46.52M | 50.59M | 45.1M | 45.99M | 42M | 41.81M | 35.75M | 42.56M |
| Gross Margin % | - | 93.3% | 94.75% | 91.47% | 92.96% | 95.13% | 94.65% | 91.11% | 88.5% | 92.36% | 92.11% | 92.4% |
| Gross Profit Growth % | -100% | 5.51% | 18.19% | 4.6% | 10.75% | 21.01% | 26.15% | 8.06% | -27.23% | -28.21% | -39.4% | -27.04% |
| Operating Expenses | 101.94M | 93.74M | 84.59M | 86.61M | 91.07M | 60.87M | 56.1M | 56.13M | 51.24M | 48.91M | 41.75M | 45.42M |
| OpEx % of Revenue | 197.11% | 163.83% | 150.36% | 164.68% | 181.99% | 114.46% | 117.73% | 111.22% | 107.96% | 108.03% | 107.55% | 98.63% |
| Selling, General & Admin | 68.36M | 62.98M | 60.27M | 64.62M | 50.08M | 39.28M | 37.57M | 39.47M | 30.09M | 23.61M | 24.77M | 28.4M |
| SG&A % of Revenue | 132.18% | 110.07% | 107.14% | 122.87% | 100.09% | 73.86% | 78.85% | 78.21% | 63.39% | 52.16% | 63.81% | 61.66% |
| Research & Development | 28.43M | 29.01M | 22.56M | 21.99M | 35.71M | 19.84M | 16.78M | 16.66M | 21.15M | 24.34M | 16.6M | 16.65M |
| R&D % of Revenue | 54.98% | 50.7% | 40.11% | 41.81% | 71.37% | 37.3% | 35.21% | 33.01% | 44.57% | 53.76% | 42.77% | 36.15% |
| Other Operating Expenses | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 0 | 0 | 953K | 380K | 378K |
| Operating Income | -50.22M | -40.35M | -31.28M | -38.5M | -44.55M | -10.28M | -11M | -10.15M | -9.23M | -7.09M | -6M | -2.87M |
| Operating Margin % | -97.11% | -70.53% | -55.61% | -73.21% | -89.03% | -19.33% | -23.08% | -20.1% | -19.46% | -15.67% | -15.45% | -6.22% |
| Operating Income Growth % | -12.74% | -292.58% | -184.4% | -279.49% | -382.39% | -44.9% | -83.49% | -253.89% | -560.83% | -207.01% | -253.4% | -182.84% |
| EBITDA | -50.22M | -34.49M | -29.23M | -36.49M | -43.57M | -8.31M | -9.03M | -8.18M | -7.01M | -5.94M | -5.42M | -2.27M |
| EBITDA Margin % | -97.11% | -60.28% | -51.96% | -69.38% | -87.07% | -15.62% | -18.96% | -16.2% | -14.77% | -13.11% | -13.95% | -4.92% |
| EBITDA Growth % | -15.27% | -315.24% | -223.6% | -346.14% | -521.44% | -39.93% | -66.81% | -261.06% | -362.19% | -181.4% | -218.08% | -154.57% |
| D&A (Non-Cash Add-back) | 0 | 5.86M | 2.05M | 2.02M | 980K | 1.97M | 1.97M | 1.97M | 2.22M | 1.16M | 580K | 602K |
| EBIT | 0 | -40.35M | -31.28M | -34.89M | -32.09M | -10.28M | -11M | -10.15M | -9.23M | -7.09M | -6M | -2.87M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.88M | 5.46M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.88M | 5.46M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.8M | 2.35M | 2.89M | 3.62M | 7.18M | 3.78M | 4.76M | 4.63M | 4.57M | 5.43M | 5.88M | 5.46M |
| Pretax Income | -48.42M | -38M | -28.39M | -34.89M | -37.37M | -6.5M | -6.24M | -5.52M | -4.66M | -1.66M | -120K | 2.59M |
| Pretax Margin % | -93.63% | -66.42% | -50.46% | -66.34% | -74.67% | -12.22% | -13.1% | -10.93% | -9.83% | -3.67% | -0.31% | 5.63% |
| Income Tax | 143K | 103.19M | -5.8M | -7.68M | -7.87M | -1.58M | -920K | -998K | -518K | 739K | -257K | 1.07M |
| Effective Tax Rate % | -0.3% | -271.53% | 20.44% | 22.01% | 21.07% | 24.4% | 14.73% | 18.09% | 11.11% | -44.49% | 214.17% | 41.36% |
| Net Income | -48.57M | -141.19M | -22.59M | -27.21M | -29.49M | -4.91M | -5.32M | -4.52M | -4.15M | -2.4M | 137K | 1.52M |
| Net Margin % | -93.91% | -246.76% | -40.15% | -51.73% | -58.94% | -9.24% | -11.17% | -8.95% | -8.74% | -5.3% | 0.35% | 3.3% |
| Net Income Growth % | -64.67% | -2774.33% | -324.23% | -502.19% | -611.38% | -104.67% | -3986.13% | -397.24% | -227.49% | -134.98% | -95.81% | -40.95% |
| Net Income (Continuing) | -48.57M | -141.19M | -22.59M | -27.21M | -29.49M | -4.91M | -5.32M | -4.52M | -4.15M | -2.4M | 137K | 1.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 | -0.08 | -0.07 | -0.04 | 0.00 | 0.03 |
| EPS Growth % | -64% | -2728.4% | -315.75% | -492.78% | -596.38% | -102.64% | - | -393.94% | -226.86% | -134.75% | -95.82% | -41.72% |
| EPS (Basic) | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 | -0.08 | -0.07 | -0.04 | 0.00 | 0.03 |
| Diluted Shares Outstanding | 59.46M | 59.1M | 58.87M | 58.99M | 58.53M | 58.31M | 58.26M | 58.22M | 57.76M | 57.53M | 57.6M | 57.54M |
| Basic Shares Outstanding | 59.46M | 59.1M | 58.87M | 58.99M | 58.53M | 58.31M | 58.26M | 58.22M | 57.76M | 57.53M | 57.52M | 57.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |